Travere Therapeutics Inc (NASDAQ:TVTX) traded at $17.68 at last check on current trade day and made a downward move of -2.24% on its previous day’s price. Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 77.53M, with a
Travere Therapeutics Inc (NASDAQ:TVTX) shares, rose in value on Thursday, March 06, with the stock price down by -2.42% to the previous day’s close as strong demand from buyers drove the stock to $18.94. Actively observing the price movement in the last trading, the stock
The trading price of Travere Therapeutics Inc (NASDAQ:TVTX) closed higher on Friday, February 28, and closing at $21.40, 3.68% higher than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $25.29 and a 52-week low
Travere Therapeutics Inc (NASDAQ:TVTX) price on current trading day, rose 1.84% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $21.03. A look at the stock’s price movement, the close in the last trading session was $20.65. Turning
Travere Therapeutics Inc (NASDAQ:TVTX) price closed lower on Friday, February 21, and dropping -6.79% below its previous close. A look at the daily price movement shows that the last close reads $23.58. Taking into account the 52-week price action we note that the stock hit
Travere Therapeutics Inc (NASDAQ:TVTX) traded at $22.66 at close of the session on Tuesday, February 18 and made a downward move of -1.09% on its previous day’s price. Travere Therapeutics Inc has a market cap of $1.97 billion and is expected to release its quarterly
Travere Therapeutics Inc (NASDAQ:TVTX) shares, rose in value on Wednesday, February 12, with the stock price down by -2.32% to the previous day’s close as strong demand from buyers drove the stock to $23.20. Actively observing the price movement in the last trading, the stock
Travere Therapeutics Inc (NASDAQ:TVTX) price on Wednesday, February 05, rose 0.52% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $21.21. A look at the stock’s price movement, the close in the last trading session was $21.10, moving
Travere Therapeutics Inc (NASDAQ:TVTX) price closed lower on Monday, February 03, and dropping -1.17% below its previous close. A look at the daily price movement shows that the last close reads $20.46, with intraday deals fluctuated between $19.67 and $20.57. The company’s 5Y monthly beta
Travere Therapeutics Inc (NASDAQ:TVTX) concluded the trading at $21.05 on Thursday, January 30 with a rise of 2.93% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $20.45 and 5Y monthly beta
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
